跳至主要内容
临床试验/NCT04812574
NCT04812574已完成3 期

Periurethral Hypertonic Saline (10%) Injection for Female Stress Urinary Incontinence and Stress-Predominant Mixed Urinary Incontinence

Turgut Ozal University2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2014年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
65
试验地点
2
主要终点
Change in the Urinary Distress Inventory-6 (UDI-6) scores at 3 months

研究概览

简要总结

The investigators aimed to evaluate the effectiveness and safety of periurethral hypertonic saline (10% NaCl) injection for the treatment of stress urinary incontinence (SUI) and stress-predominant mixed urinary incontinence (MUI) in women.

详细描述

This single-center prospective pre-post interventional study was conducted between January 2014 and April 2018 with 65 women (44 SUI, 21 MUI). Quality of life was evaluated with the Incontinence Quality of Life Scale (I-QoL) and the lower urinary tract symptoms of women were evaluated with the International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS). Incontinence status was assessed via the Stamey Incontinence Grade scale. Patients with MUI also were evaluated using the Urinary Distress Inventory-6 (UDI-6). The need for additional treatment (re-injection, other surgical approaches, etc.) was recorded.

Participants were followed up to 24 months after intervention. All outcomes of interest and complications were evaluated/recorded at six preplanned visits (postoperative 1st, 3rd, 6th, 12th, 18th, 24th months).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The patients who described Stress Urinary Incontinence or Mixed Urinary Incontinence, those who had incontinence during the Valsalva maneuver, patients with positive Marshal-Marchetti test, and those with post-void residual urine volume ≤100 mL were included in the study.

排除标准

  • Temporary urinary incontinence, delirium, urinary tract infection, urethritis, pure urge incontinence, nocturnal enuresis, decreased bladder compliance and detrusor contraction in the urodynamic study, leakage of urine with low bladder pressure, psychiatric conditions (severe depression and anxiety), body mass index (BMI) >35 kg/m2, and using drugs that may influence bladder storage or emptying

研究组 & 干预措施

Hypertonic Saline (10%) Injection

Experimental

Periurethral hypertonic saline (10%) injection was performed in female patients with Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.

干预措施: Periurethral injection (Procedure)

Hypertonic Saline (10%) Injection

Experimental

Periurethral hypertonic saline (10%) injection was performed in female patients with Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.

干预措施: Hypertonic (10%) saline (Drug)

结局指标

主要结局

Change in the Urinary Distress Inventory-6 (UDI-6) scores at 3 months

时间窗: Change from baseline at 3 months

Only MUI patients were evaluated with UDI-6 scale. UDI-6 is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women.

Change in the Stamey Incontinence Grade at 24 months

时间窗: Change from baseline at 24 months

All patients (SUI and MUI) were evaluated as follows: Grade 0: No incontinence; Grade 1: Incontinence with coughing or straining; Grade 2: Incontinence with change in position or walking; Grade 3: Total incontinence at all times

Change in the Urinary Distress Inventory-6 (UDI-6) scores at 18 months

时间窗: Change from baseline 18 months

Only MUI patients were evaluated with UDI-6 scale. UDI-6 is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women.

Change in the Urinary Distress Inventory-6 (UDI-6) scores at 24 months

时间窗: Change from baseline 24 months

Only MUI patients were evaluated with UDI-6 scale. UDI-6 is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women.

Change in the Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) scores at 24 months

时间窗: Change from baseline at 24 months

All patients (SUI and MUI) were evaluated with the ICIQ-FLUTS which is a questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life of the patients.

Change in the Incontinence Quality of Life Scale (I-QOL) scores at 3 months

时间窗: Change from baseline at 3 months

All patients (SUI and MUI) were evaluated with the I-QOL which has 22 questions with the following 3 subscales: avoid and limiting behaviors (items), psychosocial impacts (9 items), and social embarassment (5 items).

Change in the Urinary Distress Inventory-6 (UDI-6) scores at 1 month

时间窗: Change from baseline at 1 month

Only MUI patients were evaluated with UDI-6 scale. UDI-6 is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women.

Change in the Urinary Distress Inventory-6 (UDI-6) at 12 months

时间窗: Change from baseline at 12 months

Only MUI patients were evaluated with UDI-6 scale. UDI-6 is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women.

Change in the Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) scores at 18 months

时间窗: Change from baseline at 18 months

All patients (SUI and MUI) were evaluated with the ICIQ-FLUTS which is a questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life of the patients.

Change in the Incontinence Quality of Life Scale (I-QOL) scores at 24 months

时间窗: Change from baseline at 24 months

All patients (SUI and MUI) were evaluated with the I-QOL which has 22 questions with the following 3 subscales: avoid and limiting behaviors (items), psychosocial impacts (9 items), and social embarassment (5 items).

Need for addtional treatment within 6 months after internvention.

时间窗: Within the 6 months after internvention.

Patients who are needed to treat with re-injection or other surgercal approaches.

Change in the Urinary Distress Inventory-6 (UDI-6) scores at 6 months

时间窗: Change from baseline at 6 months

Only MUI patients were evaluated with UDI-6 scale. UDI-6 is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women.

Change in the Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) scores at 1 month

时间窗: Change from baseline at 1 month

All patients (SUI and MUI) were evaluated with the ICIQ-FLUTS which is a questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life of the patients.

Change in the Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) scores at 3 months

时间窗: Change from baseline at 3 months

All patients (SUI and MUI) were evaluated with the ICIQ-FLUTS which is a questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life of the patients.

Change in the Incontinence Quality of Life Scale (I-QOL) scores at 6 months

时间窗: Change from baseline at 6 months

All patients (SUI and MUI) were evaluated with the I-QOL which has 22 questions with the following 3 subscales: avoid and limiting behaviors (items), psychosocial impacts (9 items), and social embarassment (5 items).

Change in the Incontinence Quality of Life Scale (I-QOL) scores at 18 months

时间窗: Change from baseline at 18 months

All patients (SUI and MUI) were evaluated with the I-QOL which has 22 questions with the following 3 subscales: avoid and limiting behaviors (items), psychosocial impacts (9 items), and social embarassment (5 items).

Need for addtional treatment within 3 months after internvention.

时间窗: Within the 3 months after internvention.

Patients who are needed to treat with re-injection or other surgercal approaches.

Change in the Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) scores at 6 months

时间窗: Change from baseline at 6 months

All patients (SUI and MUI) were evaluated with the ICIQ-FLUTS which is a questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life of the patients.

Change in the Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) scores at 12 months

时间窗: Change from baseline at 12 months

All patients (SUI and MUI) were evaluated with the ICIQ-FLUTS which is a questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life of the patients.

Change in the Incontinence Quality of Life Scale (I-QOL) scores at 1 month

时间窗: Change from baseline at 1 month

All patients (SUI and MUI) were evaluated with the I-QOL which has 22 questions with the following 3 subscales: avoid and limiting behaviors (items), psychosocial impacts (9 items), and social embarassment (5 items).

Need for addtional treatment within 12 months after internvention.

时间窗: Within the 12 months after internvention.

Patients who are needed to treat with re-injection or other surgercal approaches.

Presence of complication within 24 months after intervention

时间窗: Within 24 months after intervention

Presence of complication such as infection at injection site, urinary tract infection, hematuria, persistent pain, de novo urge incontinence) in all patients.

Change in the Incontinence Quality of Life Scale (I-QOL) scores at 12 months

时间窗: Change from baseline at 12 months

All patients (SUI and MUI) were evaluated with the I-QOL which 22 questions with the following 3 subscales: avoid and limiting behaviors (items), psychosocial impacts (9 items), and social embarassment (5 items).

Need for addtional treatment within 24 months after internvention.

时间窗: Within the 24 months after internvention.

Patients who are needed to treat with re-injection or other surgercal approaches.

Need for addtional treatment within the 1st month

时间窗: Within the 1st month

Patients who are needed to treat with re-injection or other surgercal approaches.

Need for addtional treatment within 18 months after internvention.

时间窗: Within the 18 months after internvention.

Patients who are needed to treat with re-injection or other surgercal approaches.

次要结局

未报告次要终点

研究者

发起方
Turgut Ozal University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ibrahim Nuvit Tahtali

Principal Investigator

Turgut Ozal University

研究点 (2)

Loading locations...

相似试验

Hypertonic Saline Injection For Urinary Incontinence | 临床试验